Tomoki Naoe

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

Guoqiang Chen, Xuegeng Shi, Wei Tang et al. · PubMed · 1997 · 802 citations

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Hitoshi Kiyoi, Tomoki Naoe, Yasuyuki Nakano et al. · PubMed · 1999 · 765 citations

let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells

Yukihiro Akao, Yoshihito Nakagawa, Tomoki Naoe · Biological and Pharmaceutical Bulletin · 2006 · 628 citations · Full text

Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

Fumihiko Hayakawa, Masayuki Towatari, Hitoshi Kiyoi et al. · Oncogene · 2000 · 559 citations

Signal Transduction, Signaling Pathway, Cell Regulation +9

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

Takashi Oyama, Kazuhito Yamamoto, Naoko Asano et al. · Clinical Cancer Research · 2007 · 454 citations